NEW YORK, Jan. 23, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (NYSE: CVII), a special purpose acquisition company, announced today that it plans to transfer the listing of its shares of Class A common stock, public warrants and public units from the New York Stock Exchange ("NYSE") to Nasdaq Global Market ("Nasdaq"). Churchill VII expects that listing and trading of its securities on the NYSE will end at market close on February 2, 2024, and expects to commence trading as a Nasdaq-lis ...

UNITED STATES Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40051 | --- | --- | |------------------------------------------|---------------------| | Delaware | 85-3420354 | | (State or other jurisdiction of | (I.R.S. Employer | | ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40051 CHURCHILL CAPITAL CORP VII (Exact Name of Registrant as Specified in Its Charter) | Delaware | 85-3420354 | | --- | ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40051 CHURCHILL CAPITAL CORP VII (Exact Name of Registrant as Specified in Its Charter) | Delaware | 85-3420354 | | --- | ...

Corporate Governance - The company has adopted a Code of Ethics applicable to its directors, officers, and employees[307]. - The company has established corporate governance guidelines that cover board membership criteria and director responsibilities[308]. - The Nominating and Corporate Governance Committee identifies and recommends candidates for the board of directors[301]. - The company’s board of directors has not established specific minimum qualifications for director nominees[304]. - There were no delinquent filers for Section 16(a) reporting during the fiscal year ended December 31, 2022[306]. Conflicts of Interest - The company’s officers and directors may have conflicts of interest due to their obligations to other entities[309]. - The company’s management team is responsible for managing affairs and may have conflicts of interest in presenting business opportunities[309]. - The company may engage M. Klein and Company as its lead financial advisor for business combinations, which may create potential conflicts of interest[316]. - The company does not prohibit pursuing an initial business combination with entities affiliated with M. Klein and Company, provided an independent opinion is obtained to ensure fairness[323]. - The company’s officers and directors have multiple affiliations that may present conflicts of interest, but these are not expected to materially affect the ability to complete the initial business combination[322]. Compensation and Indemnification - The Compensation Committee is responsible for reviewing and approving the compensation of the Chief Executive Officer based on performance evaluations[301]. - The company has entered into agreements with its officers and directors for contractual indemnification, in addition to the indemnification provided in its amended and restated certificate of incorporation[327]. - The company has obtained a policy of directors' and officers' liability insurance to cover costs related to defense, settlement, or judgment payments[328]. - The company believes that its indemnification provisions and insurance are necessary to attract and retain experienced officers and directors[330]. - The company’s amended and restated certificate of incorporation limits the personal liability of directors for breaches of fiduciary duty, except as permitted by law[326]. Initial Business Combination - The company’s initial stockholders have agreed to waive their redemption rights with respect to any founder shares in connection with the initial business combination[316]. - Officers and directors have agreed to vote in favor of the initial business combination, including any public shares they may hold[325]. - The company may seek additional investments from its sponsor or affiliates in connection with the initial business combination, although there is no current obligation to do so[324]. Legal and Financial Considerations - The company’s policies may discourage stockholders from bringing lawsuits against directors for breaches of fiduciary duty, potentially affecting stockholder investments[329]. - The net proceeds from the IPO have been invested in U.S. government treasury bills, notes, or bonds with a maturity of 180 days or less, minimizing exposure to interest rate risk[268].

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40051 CHURCHILL CAPITAL CORP VII (Exact Name of Registrant as Specified in Its Charter) (Issuer's telephone number) S ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40051 | --- | --- | --- | |--------------------------------------------------------------------------------|-------------- ...

PART I - FINANCIAL INFORMATION [Item 1. Interim Financial Statements.](index=4&type=section&id=Item%201.%20Interim%20Financial%20Statements.) Presents unaudited condensed financial statements for Churchill Capital Corp VII, a SPAC, covering balance sheets, operations, equity changes, cash flows, and detailed accounting notes [CHURCHILL CAPITAL CORP VII CONDENSED BALANCE SHEETS](index=4&type=section&id=CHURCHILL%20CAPITAL%20CORP%20VII%20CONDENSED%20BALANCE%20SHEETS) | Metric | March 31, 2022 | December 31, 2021 | | :------------------------------------ | :------------- | :---------------- | | Cash | $3,865,639 | $4,155,162 | | Marketable securities held in Trust Account | $1,380,734,719 | $1,380,345,892 | | Total Assets | $1,385,554,785 | $1,385,624,642 | | Warrant Liabilities | $36,120,000 | $60,526,000 | | Total Liabilities | $84,955,070 | $109,105,250 | | Total Stockholders' Deficit | $(79,400,285) | $(103,480,608) | - Total liabilities decreased by **$24,150,180**, primarily due to a significant reduction in warrant liabilities from **$60,526,000** to **$36,120,000**[14](index=14&type=chunk) - The stockholders' deficit improved from **$(103,480,608)** at December 31, 2021, to **$(79,400,285)** at March 31, 2022[14](index=14&type=chunk) [CHURCHILL CAPITAL CORP VII CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)](index=5&type=section&id=CHURCHILL%20CAPITAL%20CORP%20VII%20CONDENSED%20STATEMENTS%20OF%20OPERATIONS%20(UNAUDITED)) | Metric | Three Months Ended March 31, 2022 | Three Months Ended March 31, 2021 | | :---------------------------------------------------- | :-------------------------------- | :-------------------------------- | | Operating costs | $714,504 | $208,027 | | Loss from operations | $(714,504) | $(208,027) | | Change in fair value of Warrant Liabilities | $24,406,000 | $(6,070,000) | | Interest earned on marketable securities held in Trust Account | $348,592 | $51,619 | | Unrealized gain (loss) on marketable securities held in Trust Account | $40,235 | $(27,468) | | Net income (loss) | $24,080,323 | $(7,650,619) | | Basic and diluted net income (loss) per share, Class A common stock | $0.14 | $(0.08) | - The company reported a net income of **$24,080,323** for the three months ended March 31, 2022, a significant improvement from a net loss of **$7,650,619** in the prior year period[16](index=16&type=chunk)[132](index=132&type=chunk)[134](index=134&type=chunk) - This shift to net income was primarily driven by a **$24,406,000** gain from the change in fair value of warrant liabilities in 2022, compared to a **$6,070,000** loss in 2021[16](index=16&type=chunk)[132](index=132&type=chunk)[134](index=134&type=chunk) [CHURCHILL CAPITAL CORP VII CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (UNAUDITED)](index=6&type=section&id=CHURCHILL%20CAPITAL%20CORP%20VII%20CONDENSED%20STATEMENTS%20OF%20CHANGES%20IN%20STOCKHOLDERS'%20DEFICIT%20(UNAUDITED)) | Metric | Balance — January 1, 2022 | Net income | Balance — March 31, 2022 | | :-------------------------- | :------------------------ | :--------- | :----------------------- | | Accumulated Deficit | $(103,484,058) | $24,080,323 | $(79,403,735) | | Total Stockholders' Deficit | $(103,480,608) | $24,080,323 | $(79,400,285) | - The total stockholders' deficit decreased from **$(103,480,608)** at January 1, 2022, to **$(79,400,285)** at March 31, 2022, primarily due to the net income of **$24,080,323** for the period[19](index=19&type=chunk) [CHURCHILL CAPITAL CORP VII CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)](index=7&type=section&id=CHURCHILL%20CAPITAL%20CORP%20VII%20CONDENSED%20STATEMENTS%20OF%20CASH%20FLOWS%20(UNAUDITED)) | Metric | Three Months Ended March 31, 2022 | Three Months Ended March 31, 2021 | | :------------------------------------ | :-------------------------------- | :-------------------------------- | | Net cash used in operating activities | $(289,523) | $(2,016,867) | | Net cash used in investing activities | $0 | $(1,380,000,000) | | Net cash provided by financing activities | $0 | $1,387,379,777 | | Net Change in Cash | $(289,523) | $5,362,910 | | Cash — End of period | $3,865,639 | $5,387,910 | - Cash used in operating activities significantly decreased from **$(2,016,867)** in Q1 2021 to **$(289,523)** in Q1 2022[26](index=26&type=chunk)[138](index=138&type=chunk)[139](index=139&type=chunk) - The 2021 cash flow figures reflect the initial investment of IPO proceeds into the Trust Account and the proceeds from the IPO and Private Placement Warrants, which were non-recurring in 2022[26](index=26&type=chunk) [CHURCHILL CAPITAL CORP VII NOTES TO CONDENSED FINANCIAL STATEMENTS MARCH 31, 2022 (UNAUDITED)](index=8&type=section&id=CHURCHILL%20CAPITAL%20CORP%20VII%20NOTES%20TO%20CONDENSED%20FINANCIAL%20STATEMENTS%20MARCH%2031%2C%202022%20(UNAUDITED)) - The notes provide detailed explanations and disclosures that are an integral part of the unaudited condensed financial statements[10](index=10&type=chunk)[24](index=24&type=chunk)[27](index=27&type=chunk) [NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS](index=8&type=section&id=NOTE%201.%20DESCRIPTION%20OF%20ORGANIZATION%20AND%20BUSINESS%20OPERATIONS) - The company is a Delaware-incorporated SPAC, formed on October 9, 2020, to effect a business combination, and has not yet commenced operations[28](index=28&type=chunk)[30](index=30&type=chunk) - The company must complete a Business Combination within **24 months** from the IPO closing (February 17, 2023), or **27 months** if a definitive agreement is in place (May 17, 2023), otherwise it will liquidate[43](index=43&type=chunk) - Management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern, though they believe a Business Combination is probable[52](index=52&type=chunk)[145](index=145&type=chunk) [NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES](index=13&type=section&id=NOTE%202.%20SUMMARY%20OF%20SIGNIFICANT%20ACCOUNTING%20POLICIES) - The financial statements are prepared in accordance with GAAP for interim financial information and SEC regulations[54](index=54&type=chunk) - The company is an 'emerging growth company' and has elected not to opt out of the extended transition period for new accounting standards[58](index=58&type=chunk)[59](index=59&type=chunk) - Warrants are classified as liabilities at fair value and re-measured each reporting period, with changes recognized in the statements of operations[69](index=69&type=chunk)[152](index=152&type=chunk) [NOTE 3. PUBLIC OFFERING](index=18&type=section&id=NOTE%203.%20PUBLIC%20OFFERING) - The company sold **138,000,000 Units** at **$10.00** per Unit in its IPO, including the full exercise of the over-allotment option[83](index=83&type=chunk) - Each Unit consists of one share of Class A common stock and one-fifth of one redeemable warrant ('Public Warrant')[83](index=83&type=chunk) [NOTE 4. PRIVATE PLACEMENT](index=18&type=section&id=NOTE%204.%20PRIVATE%20PLACEMENT) - The Sponsor purchased **32,600,000 Private Placement Warrants** at **$1.00** per warrant, generating **$32,600,000** in gross proceeds[84](index=84&type=chunk) - Proceeds from the Private Placement Warrants were added to the Trust Account[84](index=84&type=chunk) - Private Placement Warrants are non-transferable until **30 days** after a Business Combination and will expire worthless if a Business Combination is not completed within the Combination Window[84](index=84&type=chunk)[113](index=113&type=chunk) [NOTE 5. RELATED PARTY TRANSACTIONS](index=18&type=section&id=NOTE%205.%20RELATED%20PARTY%20TRANSACTIONS) - The Sponsor purchased **34,500,000 Founder Shares** (Class B common stock) for an aggregate of **$25,000** in December 2020[85](index=85&type=chunk) - The company pays an affiliate of the Sponsor **$50,000** per month for office space, administrative, and support services[89](index=89&type=chunk)[147](index=147&type=chunk) - Working Capital Loans from initial stockholders or affiliates may be used to finance transaction costs, with up to **$1,500,000** convertible into warrants; no such loans were outstanding as of March 31, 2022[92](index=92&type=chunk) [NOTE 6. COMMITMENTS AND CONTINGENCIES](index=20&type=section&id=NOTE%206.%20COMMITMENTS%20AND%20CONTINGENCIES) - The underwriters are entitled to a deferred fee of **$48,300,000**, which will be waived if the company does not complete a Business Combination[96](index=96&type=chunk)[148](index=148&type=chunk) - The company incurred due diligence fees of **$1,575,000** and legal fees of **$54,026**, which are only due and payable upon the consummation of an initial Business Combination[97](index=97&type=chunk)[98](index=98&type=chunk) [NOTE 7. STOCKHOLDERS' DEFICIT](index=20&type=section&id=NOTE%207.%20STOCKHOLDERS'%20DEFICIT) - As of March 31, 2022, there were **138,000,000 shares** of Class A common stock and **34,500,000 shares** of Class B common stock issued and outstanding[100](index=100&type=chunk)[101](index=101&type=chunk) - Holders of Class B common stock have the right to elect all of the company's directors prior to a Business Combination[104](index=104&type=chunk) - Class B common stock will automatically convert into Class A common stock on a one-for-one basis upon completion of a Business Combination, subject to adjustment[105](index=105&type=chunk) [NOTE 8. WARRANT LIABILITIES](index=22&type=section&id=NOTE%208.%20WARRANT%20LIABILITIES) - As of March 31, 2022, there were **27,600,000 Public Warrants** and **32,600,000 Private Placement Warrants** outstanding[106](index=106&type=chunk)[113](index=113&type=chunk) - Public Warrants become exercisable on the later of **30 days** after a Business Combination or **12 months** from the IPO closing[106](index=106&type=chunk) - The company may redeem Public Warrants at **$0.01** each if the Class A common stock price equals or exceeds **$18.00** for **20 trading days** within a **30-trading day period**, provided a current registration statement is in effect[109](index=109&type=chunk)[110](index=110&type=chunk) [NOTE 9. FAIR VALUE MEASUREMENTS](index=24&type=section&id=NOTE%209.%20FAIR%20VALUE%20MEASUREMENTS) - The company classifies its financial assets and liabilities measured at fair value using a three-level hierarchy: Level 1 (quoted prices in active markets), Level 2 (observable inputs other than Level 1), and Level 3 (unobservable inputs)[115](index=115&type=chunk)[116](index=116&type=chunk)[118](index=118&type=chunk) | Description | Level | March 31, 2022 | December 31, 2021 | | :------------------------------------ | :---- | :------------- | :---------------- | | Marketable securities held in Trust Account | 1 | $1,380,734,719 | $1,380,345,892 | | Warrant liability - Public Warrants | 1 | $16,560,000 | $27,600,000 | | Warrant liability - Private Placement Warrants | 3 | $19,560,000 | $32,926,000 | - Public Warrants are classified as Level 1 after detachment from Units, while Private Placement Warrants are classified as Level 3 and valued using a modified Black-Scholes model[120](index=120&type=chunk) [NOTE 10. SUBSEQUENT EVENTS](index=27&type=section&id=NOTE%2010.%20SUBSEQUENT%20EVENTS) - Management has evaluated subsequent events up to the date of financial statement issuance and identified no events requiring adjustment or disclosure[125](index=125&type=chunk) - Churchill Capital Corp VII is a Special Purpose Acquisition Company (SPAC), incorporated on October 9, 2020, formed to effect a business combination. As of March 31, 2022, the company had not commenced any operations and generates non-operating income from interest on proceeds held in its Trust Account[28](index=28&type=chunk)[30](index=30&type=chunk) - The company consummated its Initial Public Offering (IPO) on February 17, 2021, selling **138,000,000 units** at **$10.00** per unit, generating gross proceeds of **$1,380,000,000**[31](index=31&type=chunk) - Simultaneously with the IPO, the company sold **32,600,000 Private Placement Warrants** at **$1.00** per warrant, generating gross proceeds of **$32,600,000**[32](index=32&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=28&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Provides management's perspective on financial condition and operations, noting the company's blank check status, Q1 2022 net income from warrant fair value changes, liquidity, and going concern uncertainty - The company is a blank check company with no operating revenues, incurring significant costs in the pursuit of a business combination and public company compliance[129](index=129&type=chunk)[131](index=131&type=chunk) - Net income for the three months ended March 31, 2022, was **$24,080,323**, primarily driven by a **$24,406,000** gain from the change in fair value of warrant liabilities[132](index=132&type=chunk) - Cash used in operating activities for Q1 2022 was **$289,523**, a notable improvement from **$2,016,867** used in Q1 2021[138](index=138&type=chunk)[139](index=139&type=chunk) - Substantial doubt about the company's ability to continue as a going concern exists if a Business Combination is not completed by February 17, 2023 (extendable to May 17, 2023)[145](index=145&type=chunk) [Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk](index=31&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20Regarding%20Market%20Risk) The company's primary market risk exposure is interest rate risk, but due to the short-term nature of its Trust Account investments, management believes there is no material exposure - Net proceeds in the Trust Account are invested in U.S. government treasury bills with a maturity of **185 days** or less or in certain money market funds[155](index=155&type=chunk) - Due to the short-term nature of these investments, the company believes there is no associated material exposure to interest rate risk[155](index=155&type=chunk) [Item 4. Controls and Procedures](index=31&type=section&id=Item%204.%20Controls%20and%20Procedures) The CEO and CFO concluded disclosure controls were effective, and a material weakness in internal control over financial reporting related to complex financial instruments has been remediated - The Chief Executive Officer and Chief Financial Officer concluded that the company's disclosure controls and procedures were effective as of March 31, 2022[157](index=157&type=chunk) - A material weakness in internal control over financial reporting related to complex financial instruments has been remediated[159](index=159&type=chunk) - Remediation efforts included enhancing processes to apply accounting requirements, providing enhanced access to accounting literature, and engaging third-party professionals for review and oversight[159](index=159&type=chunk) Part II. Other Information [Item 1. Legal Proceedings](index=34&type=section&id=Item%201.%20Legal%20Proceedings) The company reported no legal proceedings - No legal proceedings were reported by the company[163](index=163&type=chunk) [Item 1A. Risk Factors](index=34&type=section&id=Item%201A.%20Risk%20Factors) Highlights significant risk factors, focusing on new SEC proposed rules for SPACs that could impact business combination completion, increase costs, and risk investment company classification - New SEC proposed rules (2022 Proposed Rules) relating to SPACs may materially adversely affect the company's ability to negotiate and complete a Business Combination and may increase associated costs and time[166](index=166&type=chunk) - There is a risk that the company could be deemed an 'investment company' under the Investment Company Act, which would impose burdensome compliance requirements and restrict its activities, making it difficult to complete a Business Combination[167](index=167&type=chunk)[168](index=168&type=chunk) - The 2022 Proposed Rules include a safe harbor for SPACs, requiring a business combination agreement within **18 months** and completion within **24 months** of the IPO. Failure to meet these conditions could result in the company being subject to Investment Company Act regulation[171](index=171&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=36&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) Details proceeds from the Initial Public Offering and private placement of warrants, with **$1,380,000,000** placed in the Trust Account and **$73,525,223** in transaction costs - The Initial Public Offering of **138,000,000 Units** generated total gross proceeds of **$1,380,000,000**[173](index=173&type=chunk) - The private placement of **32,600,000 warrants** to the Sponsor generated gross proceeds of **$32,600,000**[174](index=174&type=chunk) - An aggregate of **$1,380,000,000** from the IPO and private placement was placed in the Trust Account[177](index=177&type=chunk) - Transaction costs amounted to **$73,525,223**, including underwriting fees and other offering costs[178](index=178&type=chunk) [Item 3. Defaults Upon Senior Securities](index=38&type=section&id=Item%203.%20Defaults%20Upon%20Senior%20Securities) The company reported no defaults upon senior securities - No defaults upon senior securities were reported[179](index=179&type=chunk) [Item 4. Mine Safety Disclosures](index=38&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) The company reported no mine safety disclosures - No mine safety disclosures were reported[179](index=179&type=chunk) [Item 5. Other Information](index=38&type=section&id=Item%205.%20Other%20Information) The company reported no other information - No other information was reported[179](index=179&type=chunk) [Item 6. Exhibits](index=39&type=section&id=Item%206.%20Exhibits) This section lists the exhibits filed as part of the Quarterly Report on Form 10-Q, including certifications from principal executive and financial officers and XBRL-related documents - The exhibits include certifications from the Principal Executive Officer (31.1, 32.1) and Principal Financial Officer (31.2, 32.2) as required by the Securities Exchange Act and Sarbanes-Oxley Act[181](index=181&type=chunk) - XBRL Instance Document and Taxonomy Extension documents are also filed as exhibits[181](index=181&type=chunk) Part III. Signatures [SIGNATURES](index=40&type=section&id=SIGNATURES) The report is signed by Michael Klein, CEO and President, and Jay Taragin, CFO, on May 16, 2022, certifying its submission in accordance with Exchange Act requirements - The report was signed on May 16, 2022, by Michael Klein, Chief Executive Officer and President, and Jay Taragin, Chief Financial Officer[184](index=184&type=chunk)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40051 Churchill Capital Corp VII (Exact name of Registrant as specified in its Charter) Delaware 85-3420354 (State ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40051 CHURCHILL CAPITAL CORP VII (Exact Name of Registrant as Specified in Its Charter) | --- | --- | --- | |-------- ...